MARKET

DARE

DARE

Dare Bioscience
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9200
-0.0100
-1.08%
After Hours: 0.9300 +0.01 +1.09% 17:37 03/27 EDT
OPEN
0.9300
PREV CLOSE
0.9300
HIGH
0.9300
LOW
0.8800
VOLUME
116.98K
TURNOVER
--
52 WEEK HIGH
2.220
52 WEEK LOW
0.6902
MARKET CAP
22.55M
P/E (TTM)
-0.9018
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DARE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DARE stock price target is 4.500 with a high estimate of 6.00 and a low estimate of 3.000.

EPS

DARE News

More
  • The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
  • Benzinga · 9h ago
  • How Much Are Daré Bioscience, Inc. (NASDAQ:DARE) Insiders Spending On Buying Shares?
  • Simply Wall St. · 10h ago
  • Daré Bioscience to Host Fourth Quarter and Full-year 2019 Financial Results and Company Update Conference Call and Webcast on March 30, 2020
  • GlobeNewswire · 5d ago
  • Daré Bioscience (DARE) Investor Presentation - Slideshow
  • Seeking Alpha - Article · 03/19 17:38

Industry

Biotechnology & Medical Research
-2.44%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About DARE

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
More

Webull offers kinds of Dare Bioscience Inc stock information, including NASDAQ:DARE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DARE stock news, and many more online research tools to help you make informed decisions.